Diaphragmatic Echography in COVID-19 Pneumonia : Prognostic Value of Transthoracic Diaphragmatic Echography in COVID-19 Pneumonia Patients With Acute Respiratory Failure
To answer our hypothesis we will perform diaphragm ultrasound in the first 24hr hospitalized COVID19 patients.In the ultrasound exploration we will assess diaphragm movility and thickness. We will also assess other clinical, biochemistry and radiological variables. The main outcome we want to analyze is the destination on discharge: home, respiratory intermediate critical unit or exitus..
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
ClinicalTrials.gov - (2023) vom: 10. Apr. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
610 |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: April 10, 2023, Last downloaded: ClinicalTrials.gov processed this data on April 19, 2023, Last updated: April 19, 2023 |
|---|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG009123091 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG009123091 | ||
| 003 | DE-627 | ||
| 005 | 20230419030414.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230412s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG009123091 | ||
| 035 | |a (UBBS_Klinische_Studien)NCT05805579 | ||
| 035 | |a (UBBS_Klinische_Studien)ROYO1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Diaphragmatic Echography in COVID-19 Pneumonia |b Prognostic Value of Transthoracic Diaphragmatic Echography in COVID-19 Pneumonia Patients With Acute Respiratory Failure |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: April 10, 2023, Last downloaded: ClinicalTrials.gov processed this data on April 19, 2023, Last updated: April 19, 2023 | ||
| 520 | |a To answer our hypothesis we will perform diaphragm ultrasound in the first 24hr hospitalized COVID19 patients.In the ultrasound exploration we will assess diaphragm movility and thickness. We will also assess other clinical, biochemistry and radiological variables. The main outcome we want to analyze is the destination on discharge: home, respiratory intermediate critical unit or exitus. | ||
| 650 | 2 | |a COVID-19 | |
| 650 | 2 | |a Pneumonia | |
| 650 | 2 | |a Pneumonia, Viral | |
| 650 | 2 | |a Respiratory Insufficiency | |
| 650 | 4 | |a Study Type: Observational | |
| 650 | 4 | |a Recruitment Status: Completed | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2023) vom: 10. Apr. |
| 773 | 1 | 8 | |g year:2023 |g day:10 |g month:04 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT05805579 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 10 |c 04 | ||